↓ Skip to main content

PLOS

Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin Administration in Trained Men

Overview of attention for article published in PLOS ONE, February 2013
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
61 X users
facebook
4 Facebook pages

Readers on

mendeley
124 Mendeley
Title
Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin Administration in Trained Men
Published in
PLOS ONE, February 2013
DOI 10.1371/journal.pone.0056151
Pubmed ID
Authors

Jérôme Durussel, Evangelia Daskalaki, Martin Anderson, Tushar Chatterji, Diresibachew H. Wondimu, Neal Padmanabhan, Rajan K. Patel, John D. McClure, Yannis P. Pitsiladis

Abstract

Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake (v O(2 max)).

X Demographics

X Demographics

The data shown below were collected from the profiles of 61 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Australia 1 <1%
Unknown 121 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 18%
Student > Master 21 17%
Student > Ph. D. Student 20 16%
Researcher 13 10%
Other 8 6%
Other 21 17%
Unknown 19 15%
Readers by discipline Count As %
Sports and Recreations 40 32%
Medicine and Dentistry 25 20%
Agricultural and Biological Sciences 15 12%
Biochemistry, Genetics and Molecular Biology 8 6%
Nursing and Health Professions 4 3%
Other 10 8%
Unknown 22 18%